Cell Signaling Technology

SimpleChIP® Human HSPA6 Promoter Primers

#5551 · $137

100
Citing papers
10.6k
Combined citations
Supplier page Find this product

Research areas

Advanced Glycation End Products research10Genomics, phytochemicals, and oxidative stress8Cytokine Signaling Pathways and Interactions8RNA modifications and cancer6DNA Repair Mechanisms6interferon and immune responses6MicroRNA in disease regulation6Cancer Mechanisms and Therapy5

Papers citing this product

1
PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
Nature Communications·2016·560 cit.·DOI
2
PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis
Nature Communications·2014·511 cit.·DOI
3
JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
Proceedings of the National Academy of Sciences·2014·362 cit.·DOI
4
Nucleocytoplasmic Shuttling of HMGB1 Is Regulated by Phosphorylation That Redirects It toward Secretion
The Journal of Immunology·2006·362 cit.·DOI
5
Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
PubMed·2002·292 cit.
6
The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling
Cancer Research·2005·283 cit.·DOI
7
Autophagy regulates selective HMGB1 release in tumor cells that are destined to die
Cell Death and Differentiation·2008·271 cit.·DOI
8
CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation
Nature·2014·245 cit.·DOI
9
Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition
Stem Cells·2008·241 cit.·DOI
10
Human GBP1 is a microbe‐specific gatekeeper of macrophage apoptosis and pyroptosis
The EMBO Journal·2019·236 cit.·DOI
SimpleChIP® Human HSPA6 Promoter Primers — Evidence — PubIndex